Dysregulated long noncoding RNAs (lncRNAs) in hepatocellular carcinoma: implications for tumorigenesis, disease progression, and liver cancer stem cells

Molecular Cancer, Oct 2017

Hepatocellular carcinoma (HCC) is one of the most common malignant tumours with a poor prognosis worldwide. While early stage tumours can be treated with curative approaches such as liver transplantation or surgical resection, these are only suitable for a minority of patients. Those with advanced stage disease are only suitable for supportive approaches and most are resistant to the conventional chemotherapy or radiotherapy. Liver cancer stem cells (LCSCs) are a small subset of cancer cells with unlimited differentiation ability and tumour forming potential. In order to develop novel therapeutic approaches for HCC, we need to understand how the cancer develops and why treatment resistance occurs. Using high-throughput sequencing techniques, a large number of dysregulated long noncoding RNAs (lncRNAs) have been identified, and some of which are closely linked to key aspects of liver cancer pathology, progression, outcomes and for the maintenance of cancer stem cell-like properties. In addition, some lncRNAs are potential biomarkers for HCC diagnosis and may serve as the therapeutic targets. This review summarizes data recently reported lncRNAs that might be critical for the maintenance of the biological properties of LCSCs.

A PDF file should load here. If you do not see its contents the file may be temporarily unavailable at the journal website or you do not have a PDF plug-in installed and enabled in your browser.

Alternatively, you can download the file locally and open with any standalone PDF reader:

https://molecular-cancer.biomedcentral.com/track/pdf/10.1186/s12943-017-0734-4

Dysregulated long noncoding RNAs (lncRNAs) in hepatocellular carcinoma: implications for tumorigenesis, disease progression, and liver cancer stem cells

Huo et al. Molecular Cancer Dysregulated long noncoding RNAs (lncRNAs) in hepatocellular carcinoma: implications for tumorigenesis, disease progression, and liver cancer stem cells Xiaoqi Huo 0 Shuanglin Han 0 Guang Wu 0 Olivier Latchoumanin 0 Gang Zhou 0 Lionel Hebbard Jacob George 0 Liang Qiao 0 0 Storr Liver Centre, Westmead Institute for Medical Research, University of Sydney and Westmead Hospital , Westmead, NSW 2145 , Australia Hepatocellular carcinoma (HCC) is one of the most common malignant tumours with a poor prognosis worldwide. While early stage tumours can be treated with curative approaches such as liver transplantation or surgical resection, these are only suitable for a minority of patients. Those with advanced stage disease are only suitable for supportive approaches and most are resistant to the conventional chemotherapy or radiotherapy. Liver cancer stem cells (LCSCs) are a small subset of cancer cells with unlimited differentiation ability and tumour forming potential. In order to develop novel therapeutic approaches for HCC, we need to understand how the cancer develops and why treatment resistance occurs. Using high-throughput sequencing techniques, a large number of dysregulated long noncoding RNAs (lncRNAs) have been identified, and some of which are closely linked to key aspects of liver cancer pathology, progression, outcomes and for the maintenance of cancer stem cell-like properties. In addition, some lncRNAs are potential biomarkers for HCC diagnosis and may serve as the therapeutic targets. This review summarizes data recently reported lncRNAs that might be critical for the maintenance of the biological properties of LCSCs. Hepatocellular carcinoma (HCC); Liver cancer stem cells (LCSCs); Long non-coding RNAs (lncRNAs) Background Although more than 70% of the whole human genome is transcriptionally very active, only less than 2% of the transcripts are eventually translated into proteins [ 1, 2 ]. Long noncoding RNAs (lncRNAs) are a subclass of functional ncRNAs (tRNA and rRNA are not included in this review); they are over 200 nucleotides in size and are incapable of encoding protein [ 3, 4 ]. lncRNAs may share some characteristics of mRNAs [ 4 ]. For instance, lncRNAs are transcribed by RNA polymerase II; they are 5′ capped, equipped with 3′ polyA (polyadenylate) tail and consist of multiple exons [ 4, 5 ]. Initially, lncRNAs were thought to be junk or transcriptional noise since they are not well conserved across species and because expression levels were relatively lower compared with mRNAs [ 5–8 ]. However, recent studies suggest that lncRNAs play a key role in many biological processes such as X chromosome inactivation, cell cycle regulation, and cardiac development [ 4, 5, 9, 10 ]. lncRNAs are also involved in the development of many diseases. For example, using microarray analysis, a list of dysregulated (either up-regulated or down-regulated) lncRNAs have been identified in many tumour types such as prostate, liver, lung, and breast cancer [ 11–18 ]. Broadly, lncRNAs can be classified as either oncogenic or tumor-suppressive [ 19 ]. Hepatocellular carcinoma (HCC) is a leading cause of cancer related death worldwide [ 20, 21 ], with more than 500,000 new cases reported every year [22]. Early stage HCC can be effectively treated by liver transplantation or curative surgery, but for advanced cases, the therapeutic strategies are limited [ 23, 24 ]. Tumour recurrence and disease relapse after therapy, as well as drug resistance are the critical issues leading to poor prognosis [ 24, 25 ]. Within the liver tumour bulk, a small group of cells known as liver cancer stem cells (LCSCs) are considered to be responsible for the initiation, recurrence and drug resistance of HCC [ 26, 27 ]. How LCSCs are regulated at the molecular level is not well understood. Knowledge of the key regulators of LCSC behaviour would facilitate the development of more effective therapeutic approaches IIn this regard, increasing evidence has shown that lncRNAs may be involved in the regulation of the biological function of LCSCs. For example, multiple lncRNAs are expressed aberrantly in LCSCs compared to non-cancer stem cells [ 28, 29 ], while some lncRNAs are required for the self-renewal and tumour propagation of LCSCs [ 30– 32 ], or are closely associated with the clinico-pathological features [ 8, 33, 34 ]. However, the precise function of lncRNAs in LCSCs is poorly defined. This review summarizes current understanding of the lncRNAs and their implications for HCC and LCSCs. Origin and classification of lncRNA Unlike mRNA, lncRNAs are not very well conserved across species [ 8, 35 ]. These RNAs may derive from several sources: (1) insertion of a transposable element; (2) duplication of noncoding RNA; (3) transformation from a previous protein coding gene; and (4) chromatin rearrangement [ 36–38 ] (Fig. 1). In fact, lncRNAs can be generated either from prot (...truncated)


This is a preview of a remote PDF: https://molecular-cancer.biomedcentral.com/track/pdf/10.1186/s12943-017-0734-4

Xiaoqi Huo, Shuanglin Han, Guang Wu, Olivier Latchoumanin, Gang Zhou, Lionel Hebbard, Jacob George, Liang Qiao. Dysregulated long noncoding RNAs (lncRNAs) in hepatocellular carcinoma: implications for tumorigenesis, disease progression, and liver cancer stem cells, Molecular Cancer, 2017, pp. 165, Volume 16, Issue 1, DOI: 10.1186/s12943-017-0734-4